Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Report Date: November 12, 2025
Reporting Period: Fiscal quarter ended September 30, 2025
Context: The filing serves as a notification of the issuance of a press release announcing financial results for the specified quarter. The company is registered on The Nasdaq Stock Market LLC and is classified as an emerging growth company.
Key Financial Metrics
The provided Form 8-K text acts as a cover document referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not provide clear values for the following metrics:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Material Changes
The filing text does not contain specific comparative data or descriptions of material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for year-over-year or quarter-over-quarter analysis.
Guidance, Outlook, and Risks
Guidance and Outlook: The filing text does not contain forward-looking statements, guidance, or management commentary regarding future performance.
Risks and Contingencies: No specific risks or contingencies are detailed in this document. The filing includes a standard disclaimer stating that the information is not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 12, 2025) for actual financial figures and operational highlights.
- Verify the company's status as an emerging growth company and any associated reporting exemptions.
- Confirm the trading symbol (INBS) and exchange (Nasdaq) for accurate market data tracking.
- Note that the 8-K text explicitly states the information is not incorporated by reference into other filings unless specifically cited.